Ask the Expert: Gliadel Wafers

What is Gliadel®?

Gliadel Wafers are biodegradable discs about the size of a dime that contain a chemotherapeutic drug called carmustine (also called BCNU). Gliadel Wafer treatment is not suitable for all patients and brain tumour types. It can be used to treat glioblastoma multiforme if the tumour recurs.
 

How is Gliadel administered?

Gliadel Wafers are implanted directly into the cavity after the brain tumour is removed. The wafers are approximately 14mm in diameter and 1mm thick (about the size of a dime). These wafers can only be placed in the cavity by a qualified neurosurgeon during surgery to remove the tumour.
 

How does Gliadel work?

The drug remains in high concentration near the tumour site for an extended period of time allowing direct action against the cancer cells in the cavity.
 

What are the side effects of Gliadel?

Please consult your physician for a list of potential side effects.
 

Is Gliadel approved by Health Canada?

Gliadel is approved by Health Canada for use with surgery and radiation to treat newly diagnosed glioma (a type of brain cancer) and with surgery to treat recurrent glioblastoma multiforme, also a type of brain cancer.
 

Do patients have access to Gliadel?

Patients can ask their physicians for Gliadel as it is available in Canada. For more information on accessing Gliadel, please speak to your physician.
 

Is there a patient assistance program for Gliadel?

Please call Eisai Ltd. at 905-361-7130 or 1-888-551-0549 to inquire about Patient Assistance Programs.

 

Find more information about advocacy on behalf of a patient or advocacy in support of the brain tumour community in the advocacy section of the website.
Download this information as a Brain Tumour Foundation of Canada Information Sheet (pdf)

Return to Information Sheets here.

This information is provided for information purposes only, and do not represent advice, an endorsement or a recommendation, with respect to any product, service or business, and/or the claims and properties thereof, by Brain Tumour Foundation of Canada. Always consult your health care team if you have questions about your medical care and treatments options.

Share This

Featured Story

Courtney’s Story of Stability

Stability. It’s a strange concept when you have what it known to be a progressive, life long illness. You hear the words, “Your tumour growth is stable” and for a moment you think someone is playing the world’s worst prank on you.

Learn more

Spotlight

Stephen's Story: "I have faith that we will meet again"

Stephen and I chatted on what should have been his 32nd Wedding Anniversary. Stephen and Susan were married for 30 years and were best...

Learn more

Tommy's Story: Fellowship recipient

Dr. Tommy Alain, the very first research Fellow funded by Brain Tumour Foundation of Canada through the William Donald Nash Brain...

Learn more

Upcoming Events

  • 17/Jan/2018: Windsor Support Group: Meets at the United Way, Unit A1, 300 Giles Blvd. East... Learn more >
  • 17/Jan/2018: Calgary Support Group: Meets at Wellspring Calgary, 1404 Home Road NW, Calgary, Alberta, T3B 1G7... Learn more >
  • 17/Jan/2018: Niagara Region Support Group: Meets at Wellspring Niagara, 3250 Schmon Parkway, Thorold, ON, L2V 4Y6... Learn more >
  • 17/Jan/2018: Winnipeg Support Group: Sturgeon Creek United Church, 207 Thompson Drive, Winnipeg, MB... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001
35 Years